- Home
- VRRM vs KRYS Comparison
VRRM vs KRYS Comparison
Compare VRRM & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRRM
- KRYS
- Stock Information
- Founded
- VRRM 1987
- KRYS 2015
- Country
- VRRM United States
- KRYS United States
- Employees
- VRRM N/A
- KRYS N/A
- Industry
- VRRM Transportation Services
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VRRM Consumer Discretionary
- KRYS Health Care
- Exchange
- VRRM Nasdaq
- KRYS Nasdaq
- Market Cap
- VRRM 4.0B
- KRYS 4.3B
- IPO Year
- VRRM N/A
- KRYS 2017
- Fundamental
- Price
- VRRM $25.06
- KRYS $144.36
- Analyst Decision
- VRRM Strong Buy
- KRYS Strong Buy
- Analyst Count
- VRRM 4
- KRYS 10
- Target Price
- VRRM $27.88
- KRYS $204.90
- AVG Volume (30 Days)
- VRRM 732.2K
- KRYS 268.2K
- Earning Date
- VRRM 10-30-2025
- KRYS 11-03-2025
- Dividend Yield
- VRRM N/A
- KRYS N/A
- EPS Growth
- VRRM N/A
- KRYS 36.22
- EPS
- VRRM 0.24
- KRYS 4.91
- Revenue
- VRRM $906,330,000.00
- KRYS $359,205,000.00
- Revenue This Year
- VRRM $8.04
- KRYS $34.33
- Revenue Next Year
- VRRM $7.27
- KRYS $47.84
- P/E Ratio
- VRRM $104.90
- KRYS $29.46
- Revenue Growth
- VRRM 6.24
- KRYS 116.08
- 52 Week Low
- VRRM $19.51
- KRYS $122.80
- 52 Week High
- VRRM $28.25
- KRYS $207.84
- Technical
- Relative Strength Index (RSI)
- VRRM 54.31
- KRYS 47.93
- Support Level
- VRRM $23.89
- KRYS $136.73
- Resistance Level
- VRRM $25.31
- KRYS $152.96
- Average True Range (ATR)
- VRRM 0.56
- KRYS 4.98
- MACD
- VRRM -0.02
- KRYS -0.87
- Stochastic Oscillator
- VRRM 69.85
- KRYS 47.01
About VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.